These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21417820)

  • 21. A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia.
    Bradstock KF; Link E; Collins M; Di Iulio J; Lewis ID; Schwarer A; Enno A; Marlton P; Hahn U; Szer J; Cull G; Seymour JF;
    Br J Haematol; 2014 Dec; 167(5):618-25. PubMed ID: 25142189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Palifermin: anaphylaxis, oedema and hyperpigmentation. Sucking ice is safer for preventing oral mucositis.
    Prescrire Int; 2009 Dec; 18(104):257. PubMed ID: 20050200
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of head and neck cancers: issues for clinical pharmacists.
    Scarpace SL; Brodzik FA; Mehdi S; Belgam R
    Pharmacotherapy; 2009 May; 29(5):578-92. PubMed ID: 19397465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of palifermin in the prevention of oral mucositis in patients with haematological cancers].
    Ayago Flores D; Ferriols Lisart R
    Farm Hosp; 2010; 34(4):163-9. PubMed ID: 20580585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal protection by cytokines.
    Hofmeister CC; Stiff PJ
    Curr Hematol Rep; 2005 Nov; 4(6):446-53. PubMed ID: 16232381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety, Pharmacokinetics, and Efficacy of Palifermin in Children and Adolescents with Acute Leukemias Undergoing Myeloablative Therapy and Allogeneic Hematopoietic Stem Cell Transplantation: A Pediatric Blood and Marrow Transplant Consortium Trial.
    Morris J; Rudebeck M; Neudorf S; Moore T; Duerst R; Shah AJ; Graham M; Aquino V; Morris C; Olsson B
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1247-1256. PubMed ID: 26968792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the hamster cheek pouch as a model for radiation-induced oral mucositis, and evaluation of the protective effects of keratinocyte growth factor using this model.
    Watanabe S; Suemaru K; Nakanishi M; Nakajima N; Tanaka M; Tanaka A; Araki H
    Int J Radiat Biol; 2014 Oct; 90(10):884-91. PubMed ID: 24827853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New developments in management of oral mucositis in patients with head and neck cancer or receiving targeted anticancer therapies.
    Li E; Trovato JA
    Am J Health Syst Pharm; 2012 Jun; 69(12):1031-7. PubMed ID: 22644979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of radiochemotherapy-induced early oral mucositis by recombinant human keratinocyte growth factor (palifermin): experimental studies in mice.
    Dörr W; Bässler S; Reichel S; Spekl K
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):881-7. PubMed ID: 15936573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
    Hensley ML; Hagerty KL; Kewalramani T; Green DM; Meropol NJ; Wasserman TH; Cohen GI; Emami B; Gradishar WJ; Mitchell RB; Thigpen JT; Trotti A; von Hoff D; Schuchter LM
    J Clin Oncol; 2009 Jan; 27(1):127-45. PubMed ID: 19018081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging therapies for the prevention and treatment of oral mucositis.
    Yuan A; Sonis S
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):343-51. PubMed ID: 25102771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis.
    Schmidt E; Thoennissen NH; Rudat A; Bieker R; Schliemann C; Mesters RM; Zühlsdorf M; Müller-Tidow C; Berdel WE
    Ann Oncol; 2008 Sep; 19(9):1644-9. PubMed ID: 18453519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palifermin for oral mucositis in the high-dose chemotherapy and stem cell transplant setting: the Royal Adelaide Hospital Cancer Centre experience.
    Keefe D; Lees J; Horvath N
    Support Care Cancer; 2006 Jun; 14(6):580-2. PubMed ID: 16775651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palifermin: in myelotoxic therapy-induced oral mucositis.
    Siddiqui MA; Wellington K
    Drugs; 2005; 65(15):2139-46; discussion 2147-9. PubMed ID: 16225371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis.
    Stiff PJ; Leinonen M; Kullenberg T; Rudebeck M; de Chateau M; Spielberger R
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):164-9. PubMed ID: 26303102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Palifermin and chemotherapy-induced oral mucositis.
    Köstler WJ; Hejna M; Zielinski CC
    N Engl J Med; 2005 Mar; 352(12):1264-5; author reply 1264-5. PubMed ID: 15791702
    [No Abstract]   [Full Text] [Related]  

  • 38. Reduction of oral mucositis by palifermin (rHuKGF): dose-effect of rHuKGF.
    Dörr W; Heider K; Spekl K
    Int J Radiat Biol; 2005 Aug; 81(8):557-65. PubMed ID: 16298937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of keratinocyte growth factor (palifermin) administration protocols on oral mucositis (mouse) induced by fractionated irradiation.
    Dörr W; Reichel S; Spekl K
    Radiother Oncol; 2005 Apr; 75(1):99-105. PubMed ID: 15878107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keratinocyte growth factor is effective in the prevention of intestinal mucositis in patients with hematological malignancies treated with high-dose chemotherapy and autologous hematopoietic SCT: a video-capsule endoscopy study.
    Tsirigotis P; Triantafyllou K; Girkas K; Giannopoulou V; Ioannidou E; Chondropoulos S; Kalli T; Papaxoinis G; Pappa V; Papageorgiou E; Economopoulos T; Ladas SD; Dervenoulas J
    Bone Marrow Transplant; 2008 Sep; 42(5):337-43. PubMed ID: 18560408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.